GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (OTCPK:OXBDF) » Definitions » Ending Cash Position

OXBDF (Oxford BioMedica) Ending Cash Position : $103.6 Mil (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Oxford BioMedica Ending Cash Position?

Oxford BioMedica's Ending Cash Position for the quarter that ended in Jun. 2024 was $103.6 Mil.

Oxford BioMedica's quarterly Ending Cash Position declined from Jun. 2023 ($163.4 Mil) to Dec. 2023 ($131.3 Mil) and declined from Dec. 2023 ($131.3 Mil) to Jun. 2024 ($103.6 Mil).

Oxford BioMedica's annual Ending Cash Position increased from Dec. 2021 ($144.9 Mil) to Dec. 2022 ($172.1 Mil) but then declined from Dec. 2022 ($172.1 Mil) to Dec. 2023 ($131.3 Mil).

Oxford BioMedica Ending Cash Position Historical Data

The historical data trend for Oxford BioMedica's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioMedica Ending Cash Position Chart

Oxford BioMedica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.29 62.83 144.87 172.09 131.29

Oxford BioMedica Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.95 172.09 163.42 131.29 103.57

Oxford BioMedica Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Oxford BioMedica's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=178.841+-47.555
=131.3

Oxford BioMedica's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=131.954+-28.38
=103.6

Oxford BioMedica Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioMedica Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (OTCPK:OXBDF) » Definitions » Ending Cash Position
Comparable Companies
LSE:PRTC LSE:IBT LSE:4BB LSE:BVXP LSE:AVCT LSE:HVO LSE:FARN LSE:SCLP LSE:FUM LSE:TRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
OXBl:UK OXB:UK OXO:Germany OXOA:Germany
Address
Windrush Court, Transport Way, Oxford, GBR, OX4 6LT
Website
https://www.oxb.com
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.